These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9266941)

  • 1. Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity.
    Pu QQ; Bezwoda WR
    Br J Haematol; 1997 Aug; 98(2):413-7. PubMed ID: 9266941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-linolenic acid induces apoptosis in B-chronic lymphocytic leukaemia cells in vitro.
    Mainou-Fowler T; Proctor SJ; Dickinson AM
    Leuk Lymphoma; 2001 Jan; 40(3-4):393-403. PubMed ID: 11426562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
    Pu QQ; Bezwoda WR
    Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Prentice AG
    Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients.
    Frankfurt OS; Byrnes JJ; Villa L
    Leuk Res; 1997 Jan; 21(1):9-16. PubMed ID: 9029180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
    Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
    Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
    Mainou-Fowler T; Copplestone JA; Prentice AG
    J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
    Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
    Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
    Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
    Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: the role of bcl-2 and interleukin 4.
    Mainou-Fowler T; Craig VA; Copplestone AJ; Hamon MD; Prentice AG
    Leuk Lymphoma; 1995 Oct; 19(3-4):301-8. PubMed ID: 8535223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
    Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
    Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
    Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
    Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Proctor SJ; Miller S; Dickinson AM
    Leuk Lymphoma; 2001 Aug; 42(4):689-98. PubMed ID: 11697499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.
    Kay NE; Han L; Bone N; Williams G
    Br J Haematol; 2001 Mar; 112(3):760-7. PubMed ID: 11260081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
    Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
    J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL).
    Mainou-Fowler T; Miller S; Proctor SJ; Dickinson AM
    Leuk Res; 2001 Feb; 25(2):157-63. PubMed ID: 11166831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.